The antacids market is projected to reach $11.57 billion by 2030 at a 3.3% CAGR, driven by natural/herbal formulations, personalized medicine, and e-pharmacy growth.
Read More
The animal model market is projected to reach $2.97 billion by 2030 at a 7.3% CAGR, driven by AI adoption, precision medicine, genetically engineered models, and CRO expansion.
Read More
The angiotensin receptor blockers (ARBs) market is projected to reach $11.02 billion by 2030 at a 4.7% CAGR, driven by personalized hypertension care, CKD treatments, and advanced drug delivery.
Read More
The angioedema treatment market is projected to reach $6.18 billion by 2030 at a 14.5% CAGR, driven by biologics, genetic testing, hereditary treatments, and preventive care.
Read More
The angina pectoris drugs market is projected to reach $17.67 billion by 2030 at a 6.7% CAGR, driven by precision medicine, combination therapies, and telehealth cardiac care.
Read More
The anesthetics market is projected to reach $12.79 billion by 2030 at a 4.9% CAGR, driven by personalized anesthesia, AI integration, minimally invasive surgeries, and patient safety.
Read More
Anemia Drugs Market Forecast Highlights Expansion From $16.95 Billion To $22.69 Billion Through 2030
The anemia drugs market is projected to reach $22.69 billion by 2030 at a 7.6% CAGR, driven by injectable iron therapies, home healthcare, and chronic disease anemia management.
Read More
The anemia & other blood disorder drugs market is projected to reach $16.88 billion by 2030 at a 6.5% CAGR, driven by gene therapies, personalized hematology, and improved diagnostics.
Read More
The androgenetic alopecia treatment market is projected to reach $3.37 billion by 2030 at a 6.5% CAGR, driven by AI diagnostics, teledermatology, and minimally invasive hair restoration.
Read More
Androgen deprivation therapy market to hit $11.1 by 2030 at 5.9% CAGR, driven by prostate cancer cases, combo therapies, and advanced drug delivery.
Read More